Cointime

Meletios Therapeutics

company

About

Meletios Therapeutics is a biotech company that develops antiviral molecules for unmet emergency medical needs.

  • 1 - 10

Highlights

Total Funding Amount
€5.20M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology,Therapeutics,Wellness
Founded date
Apr 1, 2020
Number Of Employee
1 - 10
Operating Status
Active

Meletios Therapeutics is an operator of a biotechnology company intended to fulfill the medical need for antiviral molecules against current and emerging diseases. The company offers antiviral drugs by targeting host mechanisms that are hijacked by viruses, enabling healthcare institutions to treat a range of pathologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€5.20M
Meletios Therapeutics has raised a total of €5.20M in funding over 2 rounds. Their latest funding was raised on Nov 2, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 2, 2022 Grant €2.50M 1 European Innovation Council — Detail
Nov 2, 2022 Private Equity（PE） €2.70M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Meletios Therapeutics is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท